Author: Alberti, Adriano; Schuelter-Trevisol, Fabiana; Iser, Betine Pinto Moehlecke; Traebert, Eliane; Freiberger, Viviane; Ventura, Leticia; Rezin, Gislaine Tezza; da Silva, Bruna Becker; Meneghetti Dallacosta, Fabiana; Grigollo, Leoberto; Dias, Paula; Fin, Gracielle; De Jesus, Josiane Aparecida; Pertille, Fabiane; Rossoni, Carina; Hur Soares, Ben; Nodari Júnior, Rudy José; Comim, Clarissa Martinelli
Title: Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken Cord-id: 9ix0lftw Document date: 2021_7_16
ID: 9ix0lftw
Snippet: At the end of 2019, a new disease with pandemic potential appeared in China. It was a novel coronavirus called coronavirus disease 2019 (COVID-19). Later, in the first quarter of 2020, the World Health Organization declared the outbreak of this disease a pandemic. Elderly people, people with comorbidities, and health care professionals are more vulnerable to COVID-19. Obesity has been growing exponentially worldwide, affecting several age groups. It is a morbidity that is associated with genetic
Document: At the end of 2019, a new disease with pandemic potential appeared in China. It was a novel coronavirus called coronavirus disease 2019 (COVID-19). Later, in the first quarter of 2020, the World Health Organization declared the outbreak of this disease a pandemic. Elderly people, people with comorbidities, and health care professionals are more vulnerable to COVID-19. Obesity has been growing exponentially worldwide, affecting several age groups. It is a morbidity that is associated with genetic, epigenetic, environment factors and/or interaction between them. Obesity is associated with the development of several diseases including diabetes mellitus, mainly type 2. Diabetes affects a significant portion of the global population. Obesity and diabetes are among the main risk factors for the development of severe symptoms of COVID-19, and individuals with these conditions constitute a risk group. Based on a literature review on obesity in people with diabetes in the framework of the COVID-19 pandemic, this study presents updated important considerations and care to be taken with this population.
Search related documents:
Co phrase search for related documents- abdominal pain and absence presence: 1, 2, 3, 4, 5, 6
- abdominal pain and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and acute middle east respiratory syndrome: 1, 2, 3, 4, 5, 6
- abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal region and absence presence: 1
- abnormally high and acute infection: 1, 2
- abnormally high and acute respiratory syndrome: 1, 2, 3, 4
- absence presence and activation cleavage: 1, 2, 3
- absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- absence presence and acute middle east respiratory syndrome: 1, 2, 3
- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- absolute prevalence and acute respiratory syndrome: 1
- activation cleavage and acute infection: 1, 2
- activation cleavage and acute middle east respiratory syndrome: 1, 2
- activation cleavage and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory syndrome and adequate glycemic control: 1, 2
- acute respiratory syndrome and adequate oxygen supply: 1
- acute respiratory syndrome and adipocyte hypertrophy: 1
Co phrase search for related documents, hyperlinks ordered by date